Role of Human Leukocyte Antigens on Severe Cutaneous Drug Reactions

Main Article Content

Thachanan Kongpan
Usanee Khunakornsiri
Prarinya Konyoung
Pansu Chumworathayi
Napat Pabmeechai
Sirimas Kanjanawart
Wichittra Tassaneeyakul

Abstract

Cutaneous adverse drug reactions are the most common adverse drug reactions which range from mild forms such as rash or urticaria to severe life-threatening forms such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinophilia and systemic symptoms (DRESS) or hypersensitivity syndrome (HSS).  It has been reported that severe cutaneous adverse drug reactions from certain drugs are highly associated with the patient’s human leukocyte antigens (HLA) genotypes.  To date, the knowledge obtained from these discoveries can be applied in clinic for screening of patients who may be at risk of severe cutaneous adverse drug reactions caused by certain drugs.  This genetic test   may help to increase drug safety as well as decrease morbidity and mortality from these severe cutaneous adverse drug reactions. Keywords: Cutaneous adverse drug reactions, Human Leukocyte Antigen (HLA), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinophilia systemic symptoms (DRESS) or hypersensitivity syndrome (HSS).

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Kongpan T, Khunakornsiri U, Konyoung P, Chumworathayi P, Pabmeechai N, Kanjanawart S, Tassaneeyakul W. Role of Human Leukocyte Antigens on Severe Cutaneous Drug Reactions. Srinagarind Med J [nternet]. 1 [cited 2021Nov.29];28(1):120-3. vailable from: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/11113
Section
Review Articles